Trademark: 76201882
Status Date
Sunday, February 13, 2005
Filing Date
Thursday, January 25, 2001
Published for Opposition
Tuesday, November 20, 2001
Abandoned Date
Sunday, February 13, 2005
5 Biochemicals, namely, monoclonal antibodies and fragments thereof for clinical diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases; and cell lines for clinical diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases
May 11, 2005
Abandonment Notice Mailed - No Use Statement Filed
May 11, 2005
Abandonment - No Use Statement Filed
Aug 19, 2004
Extension 5 Granted
Aug 2, 2004
Extension 5 Filed
Aug 2, 2004
Teas Extension Received
Jul 19, 2004
Case File In Ticrs
Feb 9, 2004
Extension 4 Granted
Feb 9, 2004
Extension 4 Filed
Feb 9, 2004
Teas Extension Received
Jul 23, 2003
Extension 3 Granted
Jul 18, 2003
Extension 3 Filed
Jul 18, 2003
Teas Extension Received
Apr 18, 2003
Extension 2 Granted
Jan 22, 2003
Extension 2 Filed
Jan 27, 2003
Paper Received
Aug 14, 2002
Extension 1 Granted
Jul 12, 2002
Extension 1 Filed
Jul 22, 2002
Paper Received
Feb 12, 2002
Noa Mailed - Sou Required From Applicant
Nov 20, 2001
Published For Opposition
Oct 31, 2001
Notice Of Publication
Jun 20, 2001
Approved For Pub - Principal Register
Jun 7, 2001
Examiner's Amendment Mailed
May 11, 2001
Assigned To Examiner
May 9, 2001
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
